Clinical Trial Update: Rituximab in Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial of rituximab in metastatic melanoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Medical University of Vienna | Conditions: Metastatic Melanoma | Phase 1 | Status: TERMINATED